Tops & Flops Stocks
Security ▲ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Cara Therapeutics Inc. | -0.530% | 9.056% | 35.071% | -88.454% | -50.685% | -96.650% | -98.314% |
Caredx Inc | 2.410% | 4.599% | 20.083% | 70.588% | 50.000% | -75.143% | - |
Carisma Therapeutics Inc. | -2.100% | -3.220% | -30.823% | -79.588% | -63.796% | -98.469% | -98.284% |
CASI Pharmaceuticals Inc. | -1.850% | - | - | - | - | - | - |
Catalyst Biosciences Inc | -0.200% | - | - | - | - | - | - |
Catalyst Pharmaceutical Partners Inc | 0.590% | 4.048% | 15.267% | 27.570% | 4.215% | 240.374% | 286.193% |
Champions Oncology Inc | 0.920% | -0.905% | -5.603% | -25.128% | -9.129% | -49.364% | - |
Checkpoint Therapeutics | - | - | - | - | - | - | - |
Chembio Diagnostics Inc. | - | - | - | - | - | - | - |
Chemocentryx Inc. | 0.570% | - | - | - | - | - | - |
Chiasma Inc | -0.710% | - | - | - | - | - | - |
Chimerix Inc. | 1.990% | -1.087% | -2.033% | -22.517% | -2.430% | -86.060% | -75.769% |
Chinook Therapeutics Inc. | -1.090% | - | - | - | - | - | - |
Chromadex Corp | -1.360% | 16.000% | 20.833% | 93.333% | 119.697% | -62.581% | - |
Clovis Oncology Inc. | - | - | - | - | - | - | - |
Cocrystal Pharma Inc. | - | -5.660% | -11.504% | -10.714% | 29.032% | -81.982% | - |
Codexis Inc. | 2.790% | 3.319% | 16.493% | 6.392% | 19.051% | -81.322% | -79.604% |
Coherus Bioscien. | 1.100% | 5.090% | -1.925% | -63.648% | -48.043% | -85.770% | -89.721% |
Collegium Pharmaceutical Inc | -0.620% | 9.524% | 8.054% | 62.626% | 17.518% | 56.311% | - |
Concert Pharmaceuticals Inc. | - | - | - | - | - | - | - |
Corbus Pharmaceuticals Holding Inc. | 2.910% | 0.935% | 27.962% | 41890.669% | 41890.669% | 44.578% | -66.912% |
Corcept Therapeutics Inc. | 1.740% | 7.260% | 9.443% | 42.609% | 9.333% | 88.506% | - |
CorMedix Inc | 0.470% | 3.365% | 7.500% | 12.565% | 25.731% | -17.308% | -45.673% |
Corvus Pharmaceuticals Inc | 7.000% | 9.589% | 23.077% | 1.961% | 36.842% | 16.201% | -49.861% |
Cumberland Pharmaceuticals | -4.690% | - | - | - | - | - | - |